Stock listing

NASDAQ:NRXP NRX Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of NRX Pharmaceuticals, Inc.

Follow NRX Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:NRXP

$2.60 USD -0.11 (-4.1%)

Close on Oct 16, 2026

NRX Pharmaceuticals, Inc. logo
Ticker
NASDAQ:NRXP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • NRX Pharmaceuticals (NASDAQ:NRXP) Q2 2026 Earnings Call

    Mon, Aug 17, 2026 · 4:30 PM ET

    Watch Transcript

  • NRX Pharmaceuticals (NASDAQ:NRXP) Q1 2026 Earnings Call

    Mon, May 18, 2026 · 8:00 AM ET

    Watch Transcript

  • NRX Pharmaceuticals (NASDAQ:NRXP) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine

Oct 15, 2026

NRx Defense Systems, an NRx Company (Nasdaq: NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

Sep 30, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

Sep 15, 2026

GeNeuro, Inc., an NRx Company (Nasdaq: NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

Sep 14, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System

Sep 11, 2026

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences

Sep 8, 2026

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Aug 7, 2026

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

Jun 25, 2026

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

Jun 22, 2026

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters Option

Jun 5, 2026

All NRX Pharmaceuticals, Inc. news

Decks

NRX Pharmaceuticals, Inc. on 6ix

News releases
54 in the last 12 months · 270 in all · newest Oct 15, 2026 · oldest 2021
Calls
20 calls with a replay · 20 with a transcript · latest Aug 17, 2026
Decks
3 decks · latest Sep 14, 2026

Where NRX Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NRXP · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:A4091KLS ExchangeGermanyEUR
Lang & Schwarz:A4091KLang & SchwarzGermanyEUR
BOATS:NRXPBOATSUnited StatesUSD
gettex:B1QgettexGermanyEUR
Tradegate:B1QTradegateGermanyEUR
Frankfurt:B1QFrankfurtGermanyEUR
Hamburg:B1QHamburgGermanyEUR
Munich:B1QMunichGermanyEUR

Log in to ask 6ix AI your own questions about NRX Pharmaceuticals, Inc.